A share price of Arvinas Inc [ARVN] is currently trading at $25.13, up 0.52%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ARVN shares have gain 5.54% over the last week, with a monthly amount drifted -16.23%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Arvinas Inc [NASDAQ: ARVN] stock has seen the most recent analyst activity on February 28, 2024, when Oppenheimer reiterated its Outperform rating and also revised its price target to $80 from $95. Previously, Citigroup downgraded its rating to Neutral on February 14, 2024, and elevated its price target to $55. On February 01, 2024, Goldman initiated with a Buy rating and assigned a price target of $70 on the stock. Wells Fargo upgraded its rating to a Overweight and increased its price target to $63 on December 19, 2023. Jefferies upgraded its rating to a Buy but $40 remained the price target by the analyst firm on December 06, 2023. Guggenheim upgraded its rating to Buy for this stock on November 20, 2023. In a note dated October 23, 2023, Wedbush upgraded an Outperform rating on this stock and revised its target price from $27 to $24.
Arvinas Inc experienced fluctuations in its stock price throughout the past year between $13.57 and $53.08. Currently, Wall Street analysts expect the stock to reach $75.36 within the next 12 months. Arvinas Inc [NASDAQ: ARVN] shares were valued at $25.13 at the most recent close of the market. An investor can expect a potential return of 199.88% based on the average ARVN price forecast.
Analyzing the ARVN fundamentals
Trailing Twelve Months sales for Arvinas Inc [NASDAQ:ARVN] were 93.30M which represents 40.37% growth. Gross Profit Margin for this corporation currently stands at 0.93% with Operating Profit Margin at -3.98%, Pretax Profit Margin comes in at -3.44%, and Net Profit Margin reading is -3.47%. To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -0.56 and Total Capital is -0.4. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 24.42 points at the first support level, and at 23.70 for the second support level. However, for the 1st resistance point, the stock is sitting at 26.04, and for the 2nd resistance point, it is at 26.94.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Arvinas Inc [NASDAQ:ARVN] is 3.62. Further, the Quick Ratio stands at 3.62, while the Cash Ratio is 0.46. Considering the valuation of this stock, the price to sales ratio is 18.49, the price to book ratio is 2.87.
Transactions by insiders
Recent insider trading involved Houston John G, President and CEO, that happened on Feb 23 ’24 when 5196.0 shares were sold. Chief Financial Officer, Cassidy Sean A completed a deal on Feb 23 ’24 to sell 1702.0 shares. Meanwhile, Chief Medical Officer Peck Ronald sold 1699.0 shares on Feb 23 ’24.
